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Abstract 
 
 Drug screening is a complex and expensive process. Due to the limitations of preclinical 
testing, most drugs fail during clinical trials. No system currently available can determine a 
drug’s effect on each organ in relation to one another. This project presents the novel use of 
several decellularized leaves seeded with human cells connected on the same recirculating 
perfusion system for drug screening purposes. Decellularization is a process in which cells are 
removed from the extracellular matrix (ECM). The ECM can then be used as a substrate for new 
cells to populate, which is a process known as cell seeding. In our system, each leaf is seeded 
with a different cell type. By interconnecting these leaves, we can study cell interactions for drug 
screening purposes. Testing has shown that our system can successfully decellularize spinach 
leaves, and human cells can be successfully seeded onto the surface of these leaves.  
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I. Introduction 
Pharmaceutical companies can spend vast amounts of money on the research and 
development of various chemical compounds [1]. Researchers must evaluate their compound’s 
safety prior to clinical studies with in vitro studies assessing the impact on the major organ 
systems in the body. However, current methodologies fail to model the entire body’s response. 
These systems also lack the microvasculature network that tissue engineering lacks, thus failing 
to accurately represent entire organs and organ systems for successful drug screening purposes.  
The leaves that are present on the branches of plants have a very similar vasculature 
network to that of animals. By utilizing the natural similarities between plant and animal 
vasculature, it is thought that a plant based scaffold will provide a fully functioning vascular 
network that will supply the necessary oxygen and nutrients to the cells. Additionally, most 
leaves are connected to each other via a common vine or branch. By seeding different cell types 
onto different leaves on the same perfusion system, it is thought that the cells may be able to 
communicate with each other in a manner that is similar to the cell signaling process that occurs 
in vivo. This seeding of cells could lead to the development of organoids, which replicate organ 
functions and reactions to a drug or compound of choice. Creating a system where cells can 
communicate with each other similar to the process that occurs in vivo is of great interest to those 
involved in drug screening processes.  
 This novel idea of “organs-on-a-vine” incorporates different leaves that are present on the 
same vascular network. The different leaves were used as a scaffold for different animal cell 
types. The purpose of having the different cell types present on the same vascular network is to 
create a new drug screening tool. Current drug screening techniques are incapable of accurately 
modeling all organ systems as they are connected in vivo. A more accurate model can be created 
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by allowing different cell types to communicate through a connected perfusion system in vitro. 
This would allow for a more comprehensive drug screening process before drugs were to move 
into clinical trials.  
By creating a new technology to mimic the in vivo drug response in an in vitro 
environment, the entire drug screening process would be revolutionized. The uncertainty that is 
involved before beginning clinical trials may be reduced when assessing systemic cell reactions 
in a system that models the entire human body. Additionally, this can reduce the chance of drugs 
or compounds failing in the late stages of clinical trials due to unforeseen reactions. The natural 
active vasculature that is present in plants may be very advantageous for drug screening purposes 
as there is an abundance of plants compared to the shortage and expense of fully functioning 
animal organs.  
 The overall goal of this project was to create a system that decellularize plants which also 
allowed the user to seed animal cells onto this newly created scaffold. This system was designed 
to mimic the drug response that would occur in vivo for animals in an in vitro environment. The 
different leaves were connected onto the same perfusion network so that the system would have 
circulating vasculature to encourage cell to cell communication. Additionally, the design had to 
maintain sterility, cell viability and structural integrity of the leaf throughout the entire process in 
order to be successful.  
In order to achieve these goals, many different aspects and processes were involved. 
Initially, a system needed to be designed that would be able to perform both decellularization and 
allow for cell seeding. The design also had to connect plant material on the same vasculature 
network to encourage cell to cell communications. The design was drafted and discussed with 
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the client and all team members over multiple design iterations. Once a design was chosen, it 
was translated into a model that could be used for testing.  
The first test that were conducted on the model of the chosen design was decellularization. 
Decellularization is the process of removing cells from an existing tissue in order to isolate the 
natural extracellular matrix (ECM). After the leaves went through the process of 
decellularization, human mesenchymal stem cells were seeded onto the different leaves. 
Complete cell media was perfused through the system in order to supply the cells with the 
necessary nutrients as well as create circulating vasculature. 
The system is easy to use and satisfies the client’s need. This project was initiated in 
order to create a system that could decellularize leaves and seed human cells onto them. 
Additionally, the cells and leaves needed to be connected on the same network to encourage cell 
to cell communication. It has been demonstrated that the system can successfully decellularize 
spinach leaves connected on the same vascular network. Once the leaves are decellularized, the 
user can seed human cells back onto the leaf in a sterile hood. Complete cell media can then be 
perfused through the leaves and into a collective reservoir, to then be perfused through the leaves 
again thus encouraging cell to cell communication. 
By bringing this technology to the forefront of preclinical research techniques, areas of 
improvement were identified. Cellular reactions to compounds of interest could be quantitatively 
observed. Organoids could be created and connected on the same vascular network for drug 
screening purposes. This project has created opportunities in a new area of research involved the 
combination of plants and animals which may allow for the discovery of novel drug-screening 
technologies in the future.   
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II. Literature Review 
 
2.1 Drug Screening 
 Pharmaceutical companies spend an average of 4 billion dollars on the research and 
development of a single approved drug [1]. Researchers must evaluate their compound’s efficacy 
and more importantly, safety, prior to clinical studies. In vitro studies are completed to assess the 
impact of the drug on the major organ systems in the body. With approval from the Food and 
Drug Administration (FDA), the drug can proceed to clinical testing as can be seen in Figure 1 
[2]. An accurate model for drug screening is necessary in order to prevent drug failure in the late 
stages of clinical trials. 
 
FIGURE 1. FDA APPROVAL PROCESS [27] 
2.1.1 Current Technologies  
Numerous in vitro drug screening assays assessing the potential effects of the compound 
must prove the drug’s efficacy and safety prior to use in human subjects. At the most basic level, 
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two dimensional and three dimensional cell cultures are used for cytotoxicity and other 
assays.[3] Two dimensional cell culture is a very simple and widely used research method. 
Countless cells types can be seeded onto a flat surface under specific conditions where their 
responses can be assessed under a scope. As a method for drug screening, cells are placed on a 
plate and exposed to the compound of interest and examined for viability, proliferation rates and 
many other variables of interest. Three dimensional drug screening is a very similar experimental 
method only rather than seeding the cells onto the base of a plate, they are seeded into a three 
dimensional scaffold. These scaffolds can be made of collagen, hydrogels, and other unique 
materials. These methods, while being very cheap and very simplistic, are not a very good model 
for the complex human body. [4] 
Another method for drug screening is high throughput screening (HTS), and is named for 
the ability to assay 20,000 or more compounds per week [4]. Companies that use this method 
must have a library of compounds to choose from and must optimize that library through 
theoretical medicinal chemistry prior to initiation of the process. The screening process involves 
multi-well plates (96, 384, or 1536) and robotic assistance. An assay, multiple biological targets, 
and numerous testing compounds must be chosen. This is often a rate-limiting step in the 
development of compounds for preclinical trials. The first pass screening qualitatively checks for 
reactions [4]. Only 0.1% to 1% of compounds express a positive result, and many of those can be 
false positives, therefore a second pass is run. This process includes verifying with other assays 
and dose response testing. Out of those that passed the first screen, only 1% will pass the second 
screen and many will be impractical for drug development, due to high toxicity or low potency. 
These impracticalities are addressed using theoretical medicinal chemistry to decrease toxicity 
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and increase potency of the compound. This is the limiting step in creating new compounds for 
preclinical testing [5].  
In order to improve on the speed and functionality of HTS, research has been conducted 
into whole-animal screening. With the development of automated imaging, the worm 
Caenorhabditis elegans, the fly Drosophila melanogaster, and the fish Danio rerio can be used 
as whole animal models to screen compounds for drug creation [6]. With the use of animal 
models, the selection of particular biological targets can be eliminated, saving companies time 
and money. Additionally, progress has been made into the use of 3D human cell culture for HTS. 
As the 3D environment more closely mimics the in vivo environment, drug compounds chosen 
by this method are more effective in mouse studies [7]. However, this is an ethically 
controversial means of drug screening and there are several activist groups that oppose the use of 
animals for research purposes, one of which is People for the Ethical Treatment of Animals 
(PETA). For this reason many pharmaceutical companies are looking to different means of drug 
screening.  
Organs-on-chips is the current gold standard in modeling the body for drug screening 
purposes. Organs-on-chips are multicellular microfluidic cell culturing chips that model the 
physiological functions of tissues and organs and the dynamic environment in which they rest [3]. 
Different cells types are cultured in their own continuously perfused micro-sized chambers from 
which channels extend outwards. Porous membranes separate each cell types’ respective 
microchannels through which one can simulate and observe interactions at different tissue 
interfaces [3]. Cell chips have been developed over the past decade in order to study the effects 
that fluid flow and shear stress have on different cell types, including hepatocytes, 
cardiomyocytes, and cells from the kidney, skin, bone marrow, and lung [3].  
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The organs-on-chip design has the advantage of modeling cell to cell interactions in vitro 
so that the effects of pharmaceuticals can be tested and observed. The data that organs-on-chips 
produce help study the adsorption, distribution, metabolism, elimination, and toxicity (ADMET) 
of drugs on cells [3]. By determining these metrics, the effects of a drug on the system can be 
better understood. The organs-on-chips design allows further insight into the drug’s 
pharmacokinetics and pharmodynamics. Pharmacokinetics is the study of the ADMET metrics 
over time in a system. Pharmodynamics looks into the relationship between drug concentrations 
and the positive and negative effects on the surrounding area [8]. Due to the high number of 
variables to study and observe, organs-on-chips are good diagnostic tools for pharmaceuticals to 
look at cell to cell interaction. 
Organs-on-chips’ microfluidic analog allows researchers to study how cells from 
different tissues absorb, distribute, metabolize, and excrete any chemical compound of interest 
thus increasing the accuracy of in vitro preclinical drug assessments [3]. The chip’s 
customizability allows researchers to complete studies typically reserved for in vivo models. One 
can study, in vitro, systemic effects that a drug may induce by creating a biomimetic organism on 
a chip. Using this model for cell culture, the physical forces one might expect cells to be exposed 
to, such as mechanical compression, fluidic shear stress, and cyclic strain, can be tested and 
observed for different cell groups in vitro. Additionally, by simulating fluid flow and mechanical 
forces similar to those found in vivo one creates a more realistic in vitro model.  
There are numerous limitations of organs-on-chips. They require specialized 
microengineering in order to fit the desired applications, for oftentimes one specific chip design 
is only suitable for one specific experiment. Additionally, the materials from which these chips 
are made often will absorb drugs being screened and render the desired test inadequate. The 
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required custom fabrication from potentially unique materials may drive the system price upward 
and decrease their availability for many researchers. They also lack the ability to express active 
vasculature which may be necessary for completing studies involving the circulatory and 
endocrine systems, as well as studies involving the interaction between cells and active small 
diameter blood vessels [3]. 
2.2 Modeling Active Vasculature 
Understanding a drug’s specific pharmacodynamics is vital during the completion of 
preclinical studies. Therefore, it is in an investigator’s best interest to maximize the accuracy of 
the in vitro to in vivo extrapolation by modeling their study systems as closely to their ultimate in 
vivo counterpart.  
In order to maximize an in vitro test's accuracy, especially during drug screening, the 
simulation of active vasculature is desired. A variety of active vasculatures found in mammals is 
a system of blood vessels with capillaries separated by approximately 220 µm [9]. Cells within 
the body are exposed to drugs via diffusion from a capillary through the extracellular matrix 
(ECM) as seen in Figure 2. Biologically driven attempts at modeling active vasculature for drug 
screening in vitro have been previously investigated. High rates of angiogenesis, or small 
diameter blood vessel growth, within zebra fish have encouraged scientists to use the entire 
organism as a drug screening model [10]. Their fast reproduction rate, ease of drug 
administration, and simplicity of studying systemic effects make this a desirable substitute model 
for rats and mice. By repurposing existing tissues, such as that from plants, an in vitro system for 
drug screening which exhibits active vasculature can be developed.   
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FIGURE 2. DESCRIPTION OF DIFFUSION AND TRANSPORT PROCESSES IN VASCULARIZED 
TISSUES [28]  
 
2.3 Plant and Animal Cell Structure 
One of the largest differences between plant and animal cells is the presence of the cell 
wall. The main differences between plant and animal cells are described in Table 1. 
TABLE 1. DIFFERENCE BETWEEN PLANT AND ANIMAL CELLS 
Plant Cells Animal Cells 
Presence of a cell wall Cell membrane only 
2 vasculature networks do not connect Recirculating vasculature 
ECM is mainly composed of cellulose ECM is mainly composed of collagens 
Vasculature is constructed out of the interior of 
non-functional cells 
Vasculature is a tube constructed from cells, 
often with supporting musculature 
 
 The cell wall gives plant cells strength and support and prevents them from bursting 
from osmotic pressure. The cell wall is composed of mainly polysaccharides in two layers. The 
primary outer layer is composed mostly of cellulose, hemicelluloses, and pectins. The 
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hemicelluloses, pectins, and a variety of glycoproteins bind the cellulose fibers together, giving 
the cell wall strength. This layer regulates intercellular transport and is flexible enough to allow 
growth. The secondary layer is thicker and stronger, composed of 50 to 80% cellulose as well as 
lignin, which is a very strong polymer. This layer supports the cell more than the primary layer 
[11]. Connecting all the cells together is the middle lamella, primarily composed of pectins [12]. 
The cell wall and middle lamella are comparable to animal cell’s extracellular matrix. A diagram 
of plant cell anatomy can be found in Figure 3. 
 
FIGURE 3. PLANT CELL ANATOMY [30] 
Animal ECM is primarily composed of collagen, which is made of amino acids. There 
are several different types of collagen, as the composition varies. ECM also contains elastin, 
which allows it to stretch. Animal ECM also includes polysaccharides, though to a lesser extent 
than plants. There are glycosaminoglycans, which are similar to pectins in that they trap water to 
form gels. These are linked to a protein in order to form proteoglycans, which function in cell to 
cell signaling and cell-matrix adhesion [11]. 
Plant tissues include leaves, stems, and vascular networks. The vascular networks are the 
xylem, which carries water and dissolved minerals from the roots to the leaves, and the phloem, 
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which carries food made by the leaves to the rest of the plant. These two networks do not 
connect, unlike animal vasculature, in which the vascular network forms a recirculating system 
[13]. A histological stain of plant vasculature can be seen in Figure 4.  
 
FIGURE 4. HISTOLOGICAL IMAGE OF PLANT VASCULATURE [21] 
Xylem is composed of vessels, tracheids, fibers and parenchyma cells [14]. A vessel is a 
length of several dead cells that are connected so that water may flow through them. A single 
vessel is perforated at either end to connect to the next. Tracheids are also dead cells that conduct 
water, though they are individual cells and move water at a slower rate as each cell is not 
perforated or connected to the next. Vessels are the primary method of water transportation in 
angiosperms, flowering plants whose seeds are located in fruit [15]. Fibers and parenchyma cells 
are still alive and act as structural support.  
Phloem is composed of sieve tubes, companion cells, fibers, and parenchyma cells [16]. 
Sieve tubes are a series of cells connected by perforated cell walls. These cells lose their nuclei 
and other organelles but retain their cytoplasm, plasma membrane, mitochondria, and 
endoplasmic reticulum. These tubes are always accompanied by companion cells, specialized 
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parenchyma cells that keep the sieve tubes alive [16]. Like xylem, the fibers and parenchyma 
cells give the phloem structural support.  
The phloem and xylem are separated by the cambium, which are fully functional cells. 
The cambium is responsible for the radial growth of the plant. A representative image of a 
plant’s vasculature, including the xylem, cambium and phloem can be seen in Figure 5. 
 
FIGURE 5. PLANT VASCULATURE [21] 
Wastes are released in gaseous form through stomata on the underside of the leaves. In 
flowering plants, the xylem and phloem are organized as monocots or dicots. Monocots have 
bundles of xylem and phloem scattered around the center of the stem. In dicots, the xylem and 
phloem form concentric circles [13]. 
The xylem and phloem are continuous from the central stem into a plant's leaves. An 
individual leaf stem is called a petiole, which is often used for decellularization as it has a wide 
opening. From the petiole, the vasculature of the leaf has two forms of branching: netted or 
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parallel. Like the names suggest, netted vasculature is seen to continually branch across the 
surface of the leaf, as seen in spinach, while parallel vasculature forms parallel lines along the 
length of the leaf, as seen in a blade of grass [29]. 
Conversely, animal vasculature is composed of a layer of endothelial cells and at higher 
levels, smooth muscle cells. As the system is regularly subjected to fluctuating pressures, the 
muscle cells lend the ability to withstand those pressures while still allowing flexibility. Plant 
vasculature only flows in one direction, whereas animal vasculature recollects metabolic wastes 
and filters them separately. 
Overall, plants have a number of classification systems. A useful one is by growth form, 
divided into trees, shrubs, and herbs. Herbs are the least woody, meaning the cells have the 
thinnest cell walls and the least mechanical strength [17]. These types of plants are preferable for 
decellularization, as fluids do not require as much time to perfuse through a leaf as for trees or 
shrubs. 
2.4 Decellularization 
Decellularization refers to the process in which cells are removed from a tissue or organ 
in order to obtain the ECM for use as a scaffold. This process is widely studied and implemented 
for tissue engineering and regenerative medicine applications. Once the ECM is obtained as a 
biological scaffold, it can be used to host new cells for various applications such as implantation, 
research purposes, and potentially, drug screening [18]. There are clinical products on the market 
such as surgical mesh materials that are composed of ECM and harvested from a variety of 
allogeneic (same species) or xenogeneic (between species) tissue sources. It has been proved that 
the ECM influences cell mitogenesis and chemotaxis, directs cell differentiation, and induces 
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constructive host tissue remodeling responses. Therefore, decellularization of different tissues is 
essential in order to create clinical products to be used in the body [19]. 
The main goal of decellularization is to remove all cellular and nuclear material from the 
tissue or organ of interest, while minimizing any adverse effects to the remaining ECM. Due to 
the rigorous nature of the decellularization process, which involves both physical and chemical 
disruption of the tissue or organ of interest, the composition, biological activity or mechanical 
integrity of the ECM may be disrupted. Most decellularization processes attempt to minimize the 
disruption to the ECM in order to retain its’ natural properties while also ensuring that the tissue 
or organ can be completely rid of the cellular and nuclear components [18].  
It is important that the tissue or organ is decellularized, opposed to directly implanting a 
tissue to another patient in need, due to the inflammatory or immune-mediated rejection of the 
tissue. Most xenogeneic and allogeneic cellular antigens are recognized by the host body as 
foreign and will elicit the inflammatory or immune-mediated rejection. In order to prevent this 
response from happening, decellularization is used to remove the foreign cells from the scaffold 
of interest. The ECM and its’ components however, are generally conserved among species and 
will not elicit the inflammatory or immune-mediated rejection [18]. 
The decellularization process typically includes a combination of physical, chemical and 
enzymatic methods. The process generally begins by lysing the cell membrane, followed by 
separating the cellular components from the ECM using enzymatic treatments, solubilizing the 
cytoplasmic and nuclear components using a detergent and finally removing all cellular debris 
from the tissue [18]. All of the previously listed steps can be combined with mechanical agitation 
to gain more efficient and effective results. Any residual chemicals must be removed from the 
tissue or organ that is being decellularized in order to reduce any response from the host tissue 
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where it will eventually be used. This is usually done by flushing the tissue or organ with 
distilled water. Table 2, from Decellularization of Tissues and Organs [18], summarizes the 
commonly used decellularization methods and chaotropic agents. It is important to note that the 
exact decellularization process that is used will be dependent on the tissue or organ of interest. 
TABLE 2. COMMONLY USED DECELLULARIZATION METHODS AND CHAOTROPIC AGENTS 
FROM DECELLULARIZATION OF TISSUES AND ORGANS [12]  
Method Mode of Action Effects on ECM 
Physical 
Snap freezing Intracellular ice crystals disrupt cell 
membrane 
ECM can be disrupted or fractured during 
rapid freezing 
Mechanical force Pressure can burst cells and tissue removal 
eliminates cells 
Mechanical force can cause damage to 
ECM 
Mechanical agitation Can cause cell lysis, but more commonly 
used to facilitate chemical exposure and 
cellular material removal 
Aggressive agitation or sonication can 
disrupt ECM as the cellular material is 
removed 
Chemical 
Alkaline; acid Solubilizes cytoplasmic components of 
cells; disrupts nucleic acids 
Removes GAGs 
Non-ionic detergents 
Triton X-100 Disrupts lipid–lipid and lipid–protein 
interactions, while leaving protein–protein 
interactions intact 
Mixed results; efficiency dependent on 
tissue, removes GAGs 
Ionic detergents 
Sodium dodecyl 
sulfate (SDS) 
Solubilize cytoplasmic and nuclear cellular 
membranes; tend to denature proteins 
Removes nuclear remnants and 
cytoplasmic proteins; tends to disrupt 
native tissue structure, remove GAGs and 
damage collagen 
Sodium 
deoxycholate 
 More disruptive to tissue structure than 
SDS 
Triton X-200  Yielded efficient cell removal when used 
with zwitterionic detergents 
Zwitterionic detergents 
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CHAPS 
 
Exhibit properties of non-ionic and ionic 
detergents 
Efficient cell removal with ECM 
disruption similar to that of Triton X-100 
Sulfobetaine-10 and 
-16 (SB-10, SB-16 
 Yielded cell removal and mild ECM 
disruption with Triton X-200 
Tri(n-
butyl)phosphate 
Organic solvent that disrupts protein–
protein interactions 
Variable cell removal; loss of collagen 
content, although effect on mechanical 
properties was minimal 
Hypotonic and 
hypertonic solutions 
Cell lysis by osmotic shock Efficient for cell lysis, but does not 
effectively remove the cellular remnants 
EDTA, EGTA Chelating agents that bind divalent metallic 
ions, thereby disrupting cell adhesion to 
ECM 
No isolated exposure, typically used with 
enzymatic methods (e.g., trypsin) 
Enzymatic 
Trypsin Cleaves peptide bonds on the C-side of Arg 
and Lys 
Prolonged exposure can disrupt ECM 
structure, removes laminin, fibronectin, 
elastin, and GAGs 
Endonucleases Catalyze the hydrolysis of the interior 
bonds of ribonucleotide and 
deoxyribonucleotide chains 
Difficult to remove from the tissue and 
could invoke an immune response 
Exonucleases Catalyze the hydrolysis of the terminal 
bonds of ribonucleotide and 
deoxyribonucleotide chains 
 
 
One example of the decellularization process is the decellularization of hearts using 
methods similar to that described by H.C. Ott [14]. The aorta feeds into the coronary arteries 
which supply the cardiac muscle with blood. This makes the aorta an ideal location to perfuse the 
decellularization agents. First, the aorta of the heart is isolated, cannulated, and connected to a 
bioreactor. The heart is then perfused with heparinized phosphate buffered saline (hPBS) for 1 
hour followed by 1% sodium dodecyl sulfate (SDS) in deionized water for 48 hours. The 
heparinized PBS is used to breakup blood clots and thin any blood left in the heart. The SDS 
serves as the primary decellularizing agent. After SDS, The heart is perfused deionized water (DI 
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FIGURE 7. TIME LAPSE OF HEART DECELLULARIZATION 
water) for 12 hours. Following the deionized water 1% triton-X in deionized water is perfused 
for another 12 hours. To help prevent contamination, the heart is perfused with phosphate 
buffered saline treated with Penicillin, streptomycin, and amphotericin (aPBS) for 48 hours. 
Decellularization is then visually confirmed by a translucent appearance of the cardiac ECM. 
This entire heart decellularization processes is summarized in Figure 6[14]. 
 
FIGURE 6. HEART DECELLULARIZATION PROCESS 
 This process can also be visualized in Figure 7, in which the entire decellularization 
process is complete in 60 hours.  
Initially
• Aorta is isolated, cannulated and connected to bioreactor
1 hour
• Heart is perfused with heparinized phosphate buffered saline 
(hPBS)
48 hours
• Heart is perfused with 1% sodium dodecyl sulfate (SDS) in 
deionized (DI) water
12 hours
• Heart is perfused with DI water
12 hours
• Heart is perfused with 1% Triton-X in DI water
48 hours
• Heart is perfused with PBS treated with penicillin, streptomycin 
adn amphotericin
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 In Figure 7, the decellularized heart appears clear after 60 hours which indicates that the 
decellularization process is complete. However, it still must be confirmed that there is an absence 
of cells. This is done through fluorescence imaging and staining, which can be seen in Figure 8.  
 
FIGURE 8. (A) 40X IMAGE OF NORMAL MYOCARDIUM STAINED WITH HOECHST (BLUE) 
PHALLOIDIN (RED) (B) 40X IMAGE OF DECELLULARIZED MYOCARDIUM STAINED WITH 
HOECHST (BLUE) AND PHALLOIDIN (RED) 
Figure 8 represents the microscopic images of a normal myocardium and a decellularized 
myocardium stained with Hoechst and phalloidin at 40x magnification. Hoechst is a stain that 
will stain nucleic acids blue, thus staining the nuclei blue. Phalloidin is a stain that will stain F-
actin red, thus staining the cytoskeleton and contractile cells red. As the image on the left of the 
normal myocardium has many blue dots present, it is clear that there are many cells present. As 
the image on the right does not have any defined nuclei, it is clear that there are no cells present. 
The blue stain that can be seen in Figure 8B is nuclear material left behind in the arterioles and 
venules from incomplete washing of the heart. This image confirms a successful 
decellularization process in which the cells are removed from the extracellular matrix.  
2.5 Plant Decellularization 
As previously stated, plant decellularization is slightly different than the decellularization 
of hearts. The most successful plant decellularization has been performed on spinach leaves due 
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to their large petioles. The main differences between heart and spinach leaf decellularization 
primarily affect the perfusion time of the decellularization agents. Spinach leaves have a cuticle, 
which is a naturally waxy coating on their surface. Before the leaf can be decellularized, the 
cuticle must be removed. To remove this coating the leaf must first be submerged in hexanes and 
rinsed vigorously with PBS. This is done three times to ensure that the cuticle has been 
completely removed. The stem of the leaf is then cannulated and secured to the needle with glue 
or a suture. Once the leaf has been properly prepared it is connected to the setup and perfused 
with 10% SDS for 5 – 7 days. The leaf is then perfused with a solution of 0.1% Triton-X 100 and 
10% bleach for 24 – 48 hours. At this point decellularization is confirmed by a translucent 
appearance of the leaf. Deionized water is then perfused through the leaf for 24 hours. This entire 
process is summarized in Figure 9.  
 
FIGURE 9. PLANT DECELLULARIZATION PROCESS 
Initially
• Submerge in hexanes and vigourously rinse with PBS
Then
• Cannulate stem of leaf
5-7 Days
• Perfuse leaf with 10% SDS
24-48 Hours
• Perfuse leaf with solution of 0.1% Triton-X 100 and 10% bleach
Before 
proceding 
• Confirm decellularization by a translucent appearance
24 hours
• Perfuse leaf with DI water
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2.6 Cell Seeding  
 Cell seeding refers to the process in which cells are placed onto an external environment 
on which they will grow. Cell seeding is usually done by placing a predetermined number of 
cells onto a specific area of space to allow for cell growth. In order to seed cells onto a leaf, a 
defined protocol must be followed. First it must be ensured that the leaf is decellularized and 
sterilized. The leaf is sterilized during the last step of decellularization in which the leaf is 
perfused with 0.1% Triton-X 100 and 10% bleach for at least 24 hours until the leaf becomes 
translucent. Next, the leaf is perfused with sterile deionized water to rinse all of the 
decellularization agents and bleach from the leaf and the perfusion system for 24 hours. Once the 
perfusion system is cleared, all perfusate is aspirated and replaced with complete cell media. The 
media is perfused through the perfusion system and the leaf for 24 hours while in the incubator 
in order to equilibrate the leaf to the salinity of the media. After incubation, the leaf was chelated 
with 2mM EDTA in PBS. Next, the leaf is secured to the tray using a sterile washer. This 
ensures that the leaf surface is taught and solid to the tray. Finally, 150,000 cells are seeded onto 
the surface of the leaf within the washer. Once the cells are seeded, the entire perfusion system is 
placed back into the incubator to allow the cells to grow. This entire process is summarized in 
Figure 10. 
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FIGURE 10. PROCESS FOR SEEDING CELLS ONTO A LEAF 
III. Project Strategy 
3.1 Initial Client Statement 
         The client for our design is the Gaudette Lab. More specifically, our direct clients with 
which we had regular contact with were Professor Gaudette and a graduate student from the 
Gaudette Lab, Joshua Gershlak. The Gaudette Lab has already been able to decellularize certain 
leaves (such as spinach leaves) and use them as scaffolds for animal cell culture. However it has 
not been determined if these cells that were seeded were viable. By completing this first step in 
the process, our client, the Gaudette Lab sought to apply this technology for drug screening 
purposes. In order to achieve this goal, Professor Gaudette provided the team with this initial 
client statement: 
“One such approach that we find that could be exciting would be a systems 
biology approach or “organs on a vine”.  By decellularizing multiple leaves 
First 
•Ensure that the leaf is decellularized and sterilized
Next
•Perfuse the leaf with sterile distilled water 
Then
•Aspirate all perfusate and replace with complete cell media
For 24 hours
•Perfuse complete cell media through the perfusion system while in the incubator
Then 
•Chelate the leaf with 2mM EDTA 
Next
•Secure the leaf to the bottom of the tray using a sterile washer
Finally
•Seed 150,000 cells onto the surface of the leaf within the washer and place 
system back into incubator
22 | P a g e  
 
on the same vascular network or vine/branch, we could successfully design 
fully biomimetic body on a branch.  Different cell types could be seeded on 
different leaves or portions of the network in a way that mimics physiological 
systems in vivo.  Potential applications of this designed “organs on a vine” 
would be for drug screening and physiological testing.” 
         This provided client statement allowed the team to begin thinking about the possible 
features of the designed product.  
3.2 Design Requirements: Technical 
Objectives  
 Design objectives were created based on preliminary research and the client statement. 
Objectives are defined as “a feature or behavior that the design should have or exhibit” [20]. The 
list of objectives can be seen below listed in no particular order.  
• Protect structural integrity of the leaf throughout the entire process 
• Able to facilitate plant decellularization and cell seeding 
• Host multiple cell types on multiple leaves 
• Model active vasculature using plant anatomy 
• Provide stable extracellular substrate 
1. Protect structural integrity of the leaf throughout entire process 
 The design must protect the structural integrity of the leaf throughout the entire process. 
If the leaf becomes compromised at any point during use with the design, perfusion will not 
occur properly which may result in incomplete decellularization or cell death. The leaves become 
extremely fragile once decellularization occurs and this must be taken into account when 
designing a system to hold the leaves. 
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2. Facilitate plant decellularization and cell seeding 
         The design must facilitate decellularization and cell seeding of plants. This is a very 
important objective of the system as it will allow the system to act as a “two-in-one device”. 
Decellularized plants have natural vasculature that is very similar to that of an animal and the 
client wants to take advantage of this feature. It is believed that the vasculature of the plant itself 
will allow for cell communication similar to that which occurs in vivo in animals. By both 
decellularizing the leaf and seeding cells onto the leaf with one device, the entire process can 
occur in one place. This will also reduce the risk of sterility compromises or breakage of the leaf 
as it will remain within one device. 
3. Host multiple cell types on multiple leaves 
         The system must incorporate different cell types that are physically isolated from one 
another. Different cell types are needed so that there can be communication between different 
cell types that produce an observable reaction. The cellular communication can then be used as 
in in vitro model for drug screening as stated in the client statement.  
4. Model active vasculature using plant anatomy 
        The design must model active vasculature using plant anatomy. Active vasculature is the 
main reason why other drug screening models have failed so it is important to incorporate them 
into our design. The active vasculature present within our design will also more closely mimic in 
vivo conditions than other drug screening models.  
5. Provide stable extracellular substrate 
 The design must allow for a stable extracellular substrate. In this case, the extracellular 
substrate is the leaf itself so the design must ensure that the leaf is stable and protected. If the leaf 
is in jeopardy of being compromised in any way, such as tearing, the cells may also be in 
jeopardy which may negatively affect our design validation and any subsequent testing.  
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Constraints 
            Preliminary research, along with the client statement, were used to define design 
constraints. A constraint is defined as “a limit or restriction on the features or behaviors of the 
design. A proposed design is unacceptable if these limits are violated” [20]. Below are a list of 
the design constraints listed in no particular order. 
● Maintain cell viability 
● Must facilitate decellularization and cell seeding (maintain structural integrity of 
plant) 
● Must be sterilizable and maintain sterile environment 
● Provide/support a non-toxic extra-cellular matrix (ECM) 
● Must fit in incubator 
● Must be within budget 
1. Maintain cell viability 
 The first design constraint is to maintain cell viability. This is essential as the cells must 
be able to live and survive on the system that is created. If the cells do not survive, the system 
cannot be utilized for its intended purposes of observing the interactions between different cell 
types. 
2. Must facilitate decellularization and cell seeding while maintaining structural 
integrity of the plant 
 The second design constraint is that the system must facilitate decellularization and cell 
seeding while maintaining the structural integrity of the plant. While these were two separate 
design objectives, together they form one design constraint. If the system cannot facilitate 
decellularization and cell seeding while maintaining structural integrity of the plant, then the 
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system will have failed. The main motivations from the client were to create a device that would 
successfully recreate circulating vasculature to mimic in vivo conditions in an in vitro 
environment. If the plants are compromised or cells cannot be seeded onto them, then this unique 
environment cannot be created and the system will have failed.  
3. Must be sterilizable and maintain sterile environment  
         The third constraint is that the system must be sterilizable and maintain a sterile 
environment. This means that the system must be able to be sterilized through established means 
of sterilization without compromising the system. If the system cannot be sterilized through 
previously established sterilizing methods, then the system cannot be used for cell culture. 
Additionally, the system must maintain the sterile environment once it has been established. This 
is important as cell culture requires a sterile environment in order for the cells to survive without 
contamination.  
4. Provide/support a nontoxic extra-cellular matrix (ECM) 
         The fourth constraint is that the system must provide/support a nontoxic extracellular 
matrix. This is important as the cells need to be able to survive on the system. If the plant were to 
provide a toxic ECM, the cells may not be able to survive. Additionally, if the ECM were toxic 
due to decellularization agents that were not properly flushed from the system, the system would 
likely kill the cells and the system would fail. 
5. Must fit into incubator 
         The fifth constraint is that the system must fit/live in the incubator. This is a major 
constraint of the system as the incubators that are provided in Gateway Park and Goddard Hall at 
WPI are a specific size and the incubation space must be shared with other researchers in the lab. 
The system will have to fit inside the incubator provided so that the cells may maintain vitality. 
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6. Must be within budget 
         The sixth and final constraint is that the system must be within budget. A set budget of 
625 USD has been established for this project that cannot be exceeded in order to create the final 
design. This budget is derived from the Biomedical Engineering Department at WPI, which 
allots 125 USD per student. Additionally, if this system were to be implemented by other users, 
it needs to be cheaply manufacturable so that they can recreate our system without cost being a 
major issue.  
Functions 
 Preliminary research, along with the client statement, were used to create and define 
design functions. Functions are defined as “those things a designed device or system is supposed 
to do” [20]. The list of functions can be seen below listed in no particular order. 
● Decellularizes the plant 
● Allows user to seed cells on the plant 
● Recirculates media 
● Maintain flow to multiple leaves 
● Allows for variable flow rates between samples 
● Transportable 
● Allows user to introduce compounds to the system 
1. Decellularizes the plant 
As previously mentioned in both the objectives and constraints, the design must be able 
to decellularize the plant material. This is a major function and is essential to the success of the 
design and its functionality. If the design cannot successfully decellularize the plant, then it is 
failing to meet the client’s needs and expectations.  
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2. Allows user to seed cells on the plant 
 Our design must also allow the user to seed cells onto the plant. Similar to 
decellularization, this is a major component and is essential to its success and functionality. 
Unlike decellularization, our design does not need to physically seed the cells on the plant itself, 
rather allow the user to seed cells on the plant.   
3. Recirculates media 
 Our design must recirculate media throughout the entire system. In order for our design 
to model active vasculature and attempt to mimic in vivo conditions, recirculation of media is 
essential to transport cell signals and nutrients to all of the cells on different leaves. The 
recirculating media acts as a model of blood in vivo, which serves to transport cell signals and 
nutrients in the body.  
4. Maintain flow to multiple leaves 
 Our design must be able to maintain flow to multiple leaves. This is important because it 
is desired that multiple leaves are used to separate different cell types. Our design must be able to 
provide media to the different leaves in order to keep the cells alive. However, it is important 
that the flow is not specific to one leaf, but rather, divided among all the leaves in order to 
encourage cellular interactions.  
5. Allows for variable flow rates between samples 
 Our design should also allow for variable flow rates between samples. In the human body 
when blood is pumped from the heart, each organ receives a different percentage of the blood. In 
order to model in vivo conditions, the flow rate and overall percentage of the media that goes to 
the different leaves should be controllable. This is because the different leaves may have 
different cell types from various human organs thus creating a more accurate model.  
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6. Transportable 
 The design must be transportable without compromising sterility. This is important 
because the system must be able to move from the sterile hood to the incubator once seeded with 
cells in order maintain cell viability. This also means that the design must be relatively compact 
so that the team can easily move the system from one location to the other.  
7. Allows user to introduce compounds to the system 
 Finally, the design must allow the user to introduce compounds to the system. This will 
ultimately facilitate the drug screening process. Cellular reactions from these compounds can be 
observed in order to determine the compounds/drugs effect on those specific cells and the human 
body overall.  
3.3 Design Requirements: Standards 
 The ISO (the International Organization for Standardization) is responsible for ensuring 
that the testing of medical devices is completed in respect to an internationally agreed upon 
standard. It is important that our device and associated testing and maintenance procedures 
satisfy each ISO requirement. Section 3.7 of ISO 13485:2003 characterizes our plant based 
perfusion system as a medical device in that it “provides information for medical purposes by 
means of an in vitro examination of specimens derived from the human body”. The cells to be 
used as a diagnostic substitute in our device are specimens derived from the human body, 
therefore our entire system must satisfy all relevant ISO requirements of a medical device [22].  
Sterilization 
 To ensure that a medical device is free of any and all viable microorganisms one must 
expose it to certain conditions from a validated sterilization method and it must be observed and 
reviewed for sterility. ISO 11137 and ISO 11135 outline numerous means of validating the 
sterility of our device. The most relevant means are the Direct Transfer Sterility Test, in which 
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the sterile portion of the device is submerged in a test media which is then observed for 
microorganisms. Additionally, the Product Flush Sterility Test, in which a contact media is 
perfused through any small diameter tubing and then observed for microorganisms, must be 
completed. This contact media shall then be sent to a qualified third party for interpretation [23].  
Drafting 
 In developing a medical device, one must satisfy ISO 129-4:2013. This outlines a series 
of guidelines for technical drawings regarding their indications of dimensions, tolerances, and 
formation of draft sheets. This is done to maximize the conveying of design intention. This 
standard outlines the rules of presentation for the numerous dimensioning scenarios. This also 
describes the proper positioning of dimensions, the staggering of dimensions, the units to be used 
and general tolerances. It also describes the means of indication of special dimensions such as 
grooves, chamfers and many more. SolidWorks, the software used for the drafting of our system, 
allows default dimensioning and drafting options of ISO [24].   
Electronic controls 
 Our system is run by a pumping system that is controlled by an Arduino microcontroller. 
These controllers are an open source system that has been granted a Federal Communications 
Commission (FCC) equipment certification for complying with any requirements that are 
applicable to its scope of function [25]. Arduino coding was done using their own Integrated 
Development Environment (IDE). Coding methodologies and techniques were completed in 
compliance with the Indian Hill C Style and Coding Standards paper [26]. 
3.4 Revised Client Statement 
         Considering the most important design objectives, constraints and functions, the project 
goals were further established and the following revised client statement was created: 
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“Design a system for the decellularization and cell seeding of plants to model 
tissues in the body and their active vasculature for drug screening purposes. 
It would be ideal to acquire data on cellular reactions to compounds of 
interest. The design must maintain sterility, cell viability and structural 
integrity of the leaf throughout the entire process. ” 
         This revised client state clearly defines what the system must do and will help to shape 
the final outcomes of the design in order to satisfy the client.  
3.5 Management Approach 
Technical Approach 
         After the revised client statement was identified, objectives, functions and constraints 
were defined so that a project approach could be formulated. Initially, the team went to the 
Gaudette Laboratory to see the plant decellularization process that is currently implemented. It 
was intended that this approach would also be used for the completion of this project. 
Preliminary research was also conducted on different plants, the decellularization process and 
current in vitro models for drug screening. More specifically, the organs-on-chips technology 
was researched and its limitations were noted. 
         After preliminary research was conducted, the revised client statement was established 
and the objectives, constraints and functions were identified, the creation of alternative designs 
began. These alternative designs aimed to satisfy the revised client statement, while also 
satisfying the objectives and functions of the design and adhering to the identified constraints. 
These alternative designs were proposed by different members of the team which were recorded 
and subsequently presented to the client for further feedback. 
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 After discussing the pros and cons of each design with the client, a final design was 
selected for prototyping. The mechanical part of the design was first modeled using SolidWorks, 
which was then manufactured from acrylic sheets using a laser cutter. The different pieces of 
acrylic were mated using acrylic cement. The electrical system of the design is controlled by an 
Arduino microcontroller. By combining the electrically controlled pump and fans with a fluid 
recirculation system, the prototype was created. This prototype was then used for design testing 
and validation. 
Management Approach 
         In order to maintain good communication between the design team and the clients 
(Professor Gaudette and Joshua Gershlak), a weekly meeting schedule was established. This was 
vital in updating the clients on the progress of the project and reviewing the work that was 
previously completed. This meeting was also used as a time for discussion in which ideas and 
questions could be communicated. In order to keep the project on track, milestones were created 
in terms of the project management using a Gantt chart, which can be seen in Appendix E: Gantt 
Chart. There are many major milestones included: defining the client statement, defining 
objectives, constraints, functions and means, generating design alternatives, choosing a design, 
design construction, design validation and data collection, and finally data analysis. 
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IV. Design Process 
4.1 Needs Analysis 
 Chapter 3 outlines the objectives that were established from the revised client statement. 
In order to prioritize these objectives for the design process a weighted objectives scale was 
created, in which each objective was given a score from 1-10, 1 indicating low priority and 10 
indicating necessity for the function of the device. The objectives with their respective scores can 
be seen in Table 3. 
 TABLE 3. WEIGHTED OBJECTIVES SCALE FOR THE FINAL DESIGN 
Objectives Score 
Able to facilitate plant decellularization 
and cell seeding  
10 
Protect structural integrity of leaf 9 
Ability to host multiple cell types on 
multiple leaves 
8 
Model active vasculature using plant 
anatomy 
10 
Provide stable extracellular substrate 8 
  
 The first objective “able to facilitate plant decellularization and cell seeding” was given a 
score of 10 as it is necessary for function of the device. Decellularization and cell seeding are the 
two main functions of the device and if the design does not allow for these functions to occur, 
then the device will have failed. The design must also “protect the structural integrity of the leaf”, 
but was given a 9 on this weighted objectives scale. It is important that the structural integrity of 
the leaf is protected so that the cells seeded on the leaf survive. However, the entire leaf does not 
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need to be protected, only the stem and the area with the seeded cells which is why this objective 
received a score of 9 instead of a 10.  
 The design must also be able to “host multiple cell types on multiple leaves”. This 
objective was given a score of 8 because this will allow for the creation of organoids and 
subsequent drug screening. However, this project was centered on testing one leaf, allowing for 
the use of multiple leaves in the future. The next objective is to “model active vasculature using 
plant anatomy” which was given a score of 10. This is essential to the design as the utilization of 
plants was the client’s initial motivation for this project. Additionally, plant material has active 
vasculature that current drug screening technologies have limited capacity in recreating.  
 The last objective is to “provide a stable extracellular substrate”. This objective was 
given a score of 8 because the design may be able to succeed if the extracellular substrate was 
not stable, however it would make the design very difficult to handle.  For example if the leaf 
were not supported, the cells may still survive, but there is a possibility the structural integrity 
leaf may be damaged due to transportation. Using the weighted objectives scale in Table 3, 
conceptual designs were drafted in order to satisfy the objectives for this design.  
4.2 Conceptual Designs and Feasibility Studies 
 The team established various conceptual designs that would allow for both the 
decellularization and cell seeding of plant material with recirculating vasculature. It was essential 
that these conceptual designs would have the capacity to adhere to all of our defined objectives, 
constraints, and functions. Descriptions of these conceptual designs are provided in the following 
sections along with each designs advantages and limitations. Feasibility studies were also 
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conducted in order to determine if specific aspects of our design would be feasible. The set-up 
and results of these studies are described in the following sections.  
Conceptual Design 1: Utilization of Leaves on a Vine 
 One of the team’s conceptual designs involved using an entire vine, with the leaves 
included, as the plant material that would be used in this system. This design would be connect 
the vine with itself using a pump and sterile tubing in order to create a recirculating system. A 
single collection bin would sit under the vine and collect the perfusate which would feed back 
into the pump and throughout the entire system. 
 One advantage of this system is that it utilizes the entire vine. All of the available plant 
anatomy would be used and would satisfy the client’s initial motivations. The disadvantages to 
this system are that the actual vine only provides a one way directional flow due to a plant’s 
natural anatomy. Additionally, if a vine were to be used, it would be fairly difficult to control the 
rate of flow to the different leaves. Finally, using a single vine may create the possibility of 
universal flow failure if the perfusate were to get clogged at any one point in the system.  
Conceptual Design 2: Utilization of Leaves and Tubing 
In the team’s second conceptual design, leaves were considered as the main portion of the 
plant material that would be used. In this system, the leaves would be connected using sterile 
tubing. The tubing would provide a system to connect the leaves and provide recirculating 
vasculature.  
 The advantages of this design are that the leaves represent the type of vasculature that 
most closely mimics that present in vivo. This is important as it is the main reason our client 
wanted us to utilize leaves and their nature vasculature. Additionally, the leaves allow for a large 
surface area in which cells could inhabit. The disadvantages to this design are that the tubing is 
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not a natural part of the plant which deviates from utilizing all of the natural anatomy available 
to us. Another disadvantage is that when leaves are perfused, they evacuate the liquid out 
through the stoma meaning that collecting this perfused liquid with tubing may be difficult.  
Conceptual Design 3: Utilization of a Polydimethylsiloxane (PDMS) Mold 
 The next conceptual design involved the use of a custom-made PDMS mold to encase 
each individual leaf. The purpose of encasing each leaf is to maintain sterility and also to help 
facilitate the path of perfusion. The perfusate would travel throughout the entirety of the leaf and 
the PDMS mold would channel the fluid into the next leaf. This system can be used for any 
number of desired leaves. The pump keeps the perfusate moving through all the elements 
without the need for a collection area. Each PDMS mold would encase the leaf with minimal 
extra space. There would be 3 openings in each mold, one for flow in, one for flow out, and one 
for air recirculation with a High-Efficiency Particulate Arrestance (HEPA) filter. Each individual 
PDMS mold, which encases one leaf, would be connected via sterile tubing. Pump-mediated 
perfusion would be utilized to create a recirculating system.  
 One advantage of this design is that it controls the directionality of perfusion by using the 
custom made PDMS mold. Additionally, as the design is composed of multiple sterile chambers, 
it reduces the chance of contamination.  
 The disadvantages of this design are that the individual PDMS molds may be difficult to 
keep sterile if the leaves need to be handled or replaced often. As the leaf chambers are 
connected in series, it limits the perfusion rate of fluid and may also cause universal failure in the 
event of a clog. Additionally, there is a limit to the number of leaves the design can support. This 
is because each leaf would create a pressure drop that would need to be compensated for with an 
increased pump pressure, potentially destroying the first leaf if the pressure required is too high. 
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In order to keep the cells on the leaves alive, the media would have to be changed regularly. As 
there is no collection chamber, this would have to be done very slowly through a needle at a 
sterile port. This also presents the difficulty of collecting samples for testing. 
Feasibility Study 1: Determining the best method of cannulation 
Once the leaves are decellularized, they become extremely fragile and movement can 
compromise the structural integrity of the stem. This is because the needle may poke through the 
petiole and cause subsequent issues with perfusion and fluid flow. In order to prevent this issue, 
a feasibility study was conducted to determine the best method of cannulation. Two methods of 
cannulation were tested. The first method was the silicone glue method. This involved inserting 
the needle into the leaf via the petiole and then encasing the entire petiole in a silicone glue that 
was allowed to cure. The second method was the clip method. This involves inserting the needle 
into the leaf via the petiole, and then encasing the entire petiole in a rigid plastic clip. Both leaves 
were decellularized via cannulation. Once decellularization was complete, a red dye was 
perfused via the needle into the leaves. This allowed for observation of perfusion throughout the 
leaf to observe if the petiole had been compromised during the decellularization process. The set-
up and results of this study can be seen inFigure 11. 
 
FIGURE 11. SILICONE GLUE METHOD SET UP, DECELLULARIZATION AND RED DYE TEST 
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 Figure 11 shows the set up for the silicone glue method and the decellularization of the 
leaf after seven days. The red dye test is also shown and it is clear that only one side of the leaf is 
being perfused with the red dye. This is due to the fact that the petiole had been compromised by 
the needle. In the beginning the perfusate would bubble out of the petiole and fall to the bottom 
of the leaf. However, after 20 minutes, one side of the leaf began to be perfused by the red dye. 
The results show that the petiole had been compromised and the silicone glue method had failed.  
 Figure 12 shows the set up for the clip method and the red dye test. The red dye for this 
leaf is more evenly distributed throughout the leaf and it is clear that the entire leaf would be 
perfused after a certain period of time. This indicates that the structural integrity of the leaf and 
petiole remained intact, which proves that the clip method was successful. Based on these results, 
the team decided to use the clip method for all remaining experimentation with the design and 
implement the use of the clips into the final design.  
 
FIGURE 12. CLIP METHOD AND RED DYE TEST 
Feasibility Study 2: Flow Regulation  
 For a possible final design, our team examined the idea of having the leaves connected in 
parallel, rather than in series. In order to allow flow to run in parallel, a manifold was 
implemented to divide the flow of fluid among all the leaves. The specific manifold that was 
38 | P a g e  
 
used was a polycarbonate individual manifold, with 5 ports and 360° rotation (Cole Palmer). The 
manifold was used in conjunction with tubing, T-splitters, tubing connectors and pinch valves, if 
applicable. Tubing was connected to a main collection beaker, which would then connect to a T-
splitter where two different pieces of tubing were connected. The two pieces of tubing were then 
connected to either end of the manifold. This design allowed for a basic setup that could be used 
as a control to see if there was an even distribution of flow to all of the outlet ports. A 
representative image of the test set-up can be seen in Figure 13. 
 
FIGURE 13. REPRESENTATIVE IMAGE OF FLOW REGULATION TESTING SET-UP 
 The first test that was conducted was a control test. This test consisted of pouring 1000 
mL of distilled water into the top beaker and stopping flow to the outlet ports. Then, water was 
allowed to run through three of the total five outlet ports for 30 seconds. Graduated cylinders 
were placed below each outlet port to collect the water. Once the 30 seconds passed, the flow of 
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water was stopped. The amount of water in each graduated cylinder was then recorded and 
converted into percentages. This was done using the equation:𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑤𝑤𝑤𝑤𝑤𝑤𝑜𝑜𝑜𝑜
𝑤𝑤𝑜𝑜𝑤𝑤𝑤𝑤𝑡𝑡 𝑤𝑤𝑤𝑤𝑤𝑤𝑜𝑜𝑜𝑜  × 100. This 
allowed for the calculation of the percentage of water in each beaker so that it could be compared 
to the expected percentage. This test was completed a total of five times and an average 
percentage was calculated for each outlet port. Since a three outlet manifold was implemented, a 
33.33% distribution was expected in each beaker. As seen in Figure 14, beaker 1 received 30%, 
beaker 2 received 35.86% and beaker 3 received 34.09% of the total water. 
 
FIGURE 14. CONTROL RESULTS FOR FLOW REGULATION EXPERIMENTS 
 Although none of these values exactly correlate to 33.33%, they are still statistically 
significant with a p-value of 8.89*10-7. Additionally, as this is the control test, this specific 
distribution of water is important to take into account for the other flow experiments that were 
conducted.  
This control test allows us to run flow in parallel with a working manifold for our final 
design. However, this specific set-up does not accurately represent physiological function. In the 
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human body, when blood is pumped from the heart it is not evenly distributed. Each organ 
receives a different percentage of the total blood, so this must be accounted for in the final design 
if in vivo conditions are going to be represented as closely as possible. A solution to representing 
this in our final design was the use of pinch valves. Specifically, the design utilizes Flow Control 
Needle Pinch Valves from the United States Plastic Corporation as seen in Figure 15. These 
valves can be used to control fluid flow by occluding the tubing. Each clamp has an adjustment 
range of 10 millimeters (mm) so the occlusion of the tubing can be quantitatively measured.  
 
 
FIGURE 15. PINCH FLOW VALVES 
 The tubing that was used for testing would allow the pinch valve to close to 8 mm before 
contacting the tubing. It was also found through trial-and-error that the pinch valve could close to 
4 mm while maintaining an equal flow rate to unrestricted tubing. The difference in flow from 
the unrestricted tubing was only apparent once the valve was closed to 3 mm.  
 A single channel test was conducted to see how each pinch valve would control flow 
without the influence of the other pinch clamps or outlet ports. In order to get a good 
representation of the flow profile, every half millimeter was tested. 1000 mL of water was 
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poured into the top beaker and allowed to run through one outlet port with a pinch valve for five 
seconds. Each setting on the pinch valve was tested five times and the average was calculated. 
These results can be seen in Figure 16.  
.  
FIGURE 16. SINGLE CHANNEL FLOW RESULTS 
 By using only one flow channel it was show that the pinch valves are able to regulate the 
flow, but with very small changes in every half millimeter increment until 2.5 mm. Although this 
does not show that the pinch valves are effective in regulating flow, it is important to note that 
multiple pinch valves will be used with multiple outlet ports for our final design. Due to this fact, 
testing with multiple outlet ports was essential.   
As it was expected that pinch valves would be used in conjunction with multiple leaves, a 
pinch valve was placed on each of the three outlets that were used in the control test. A set up of 
this testing can be seen in Figure 17. 
39.4
38.4 38 38
35.4
29.8
13.1
0
0
5
10
15
20
25
30
35
40
45
50
m
L 
H
20
Single Channel Flow for 5 Seconds
Control 4mm 3.5mm 3mm 2.5mm 2mm 1.5mm 1mm
42 | P a g e  
 
 
FIGURE 17. FLOW RESTRICTION TESTING SET-UP 
 The pinch valves were all set to different restrictions (the largest being 4 mm) in order to 
determine the ability of the pinch valves to regulate flow. 1000 mL of water was added to the top 
beaker and the water was allowed to flow for 30 seconds. Each experimental set-up was tested 
five times and the average for each outlet port was calculated. For one trial, the pinch valves for 
beaker 1 and beaker 2 were set to be open 2 mm and the pinch valve on beaker 3 was set to be 4 
mm open. This indicates that one would expect 25% of the water in beaker 1 and beaker 2 and 
50% of the water in beaker 3. The results obtained can be seen in Figure 18. 
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FIGURE 18. TEST 3 FLOW RESULTS 
 The results that were obtained were that the first beaker got 26% of the total water 
(compared to the expected 25%), the second beaker got 29% of the total water (compared to the 
expected 25%), and the third beaker got 45% of the total water flow (compared to the expected 
50%).  
 For a different trial, the pinch valve for beaker 1 was set to 2 mm, the pinch valve for 
beaker 2 was set to 3 mm and the pinch valve for beaker 3 was set to 2 mm. This indicates that 
one would expect to see 28.6% of the total water in the first and third beaker and 42.8% of the 
total water in the second beaker. The actual results that were obtained can be seen in Figure 19. 
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FIGURE 19. TEST 5 FLOW RESULTS 
 The first beaker received 24.6% of the total flow (compared to the expected 26.8%), the 
second beaker received 48% of the total flow (compared to the expected 42.8%) and the third 
beaker received 27.4% of the total flow (compared to the expected 27.4%). 
 For the final test, the pinch valves for beakers 1 and 3 were set to 3 mm and the pinch 
valve for beaker 2 was set to 2 mm. This indicates that one would expect to see 37.5% of the 
total water in the first and third beaker and 25% of the total water in the second beaker. The 
results obtained can be seen in Figure 20.  
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FIGURE 20. TEST 4 FLOW RESULTS 
 The results were that the first beaker got 35% of the total flow (compared to the expected 
37.5%), the second beaker got 24.1% of the total flow (compared to the expected 25%) and the 
third beaker got 40.9% of the total flow (compared to the expected 37.5%). Overall it is clear that 
the pinch valves are effective in regulating flow when multiple pinch valves are used in parallel. 
Additionally, these pinch valves are important as the amount of flow that is regulated can be 
quantitatively recorded. It does not necessarily matter how much water goes to each outlet, but 
that the ratio of the water flow to each different outlet port can be controlled in order to model in 
vivo conditions.   
Feasibility Study 3: Pressure Regulation 
To achieve a more compact device with leaves resting horizontally, and to maintain 
consistant perfusate flow through the leaf, a pump mediated pressure regulator was created. An 
Arduino microtcontroller, which receives data from a pressure transducer, controls a parastaltic 
pump. To assess this regulation system's capability of maintaining a constant pressure within the 
leaf, data was collected under two different conditions. Condition one involved the pumping of 
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fluid through an open tube with no leaf attached, while the second condition involved pumping 
through a leaf. The pressure measurements for both setups can be seen in Figure 21 and Figure 
22. Through the electronically regulated pressure fluctuates more, this fluctuation is controlled 
and due to the pulsatile nature of the peristaltic pump. The fluctuations in pressure recorded from 
the mechanical pressure head are not controlled and sue to its passive nature is prone to 
becoming clogged.  These results indicate that it is possible to develop a compact system that 
actively pulses perfusate within a specified range.  
  
 
FIGURE 21. PRESSURE WITH LEAF 
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FIGURE 22. PRESSURE WITH NO LEAF 
4.3 Alternative Designs 
 The team established various alternative designs that would allow for both the 
decellularization and cell seeding of plant material with recirculating vasculature. These differ 
from conceptual designs in that they are more detailed and their mechanical set-up is very 
specific. It was essential that these alternative designs also have the capacity to achieve all of our 
defined objectives, constraints and functions. Descriptions of these alternative designs are 
provided in the following sections along with each designs advantages and limitations. 
Pump mediated perfusion system of stems placed in series 
The first alternative design utilized stems as the main portion of the plant material that 
would be used as seen in Figure 23. Tubing would be arranged in a circle so that the perfused 
liquid could continuously move through all of the stems. Additionally, a pump would be used to 
create flow which could flow in either direction. This design would not require a collection bin 
as the perfusate would be contained within the stem pieces or tubing. Tubing would be arranged 
in a circle so that the perfused liquid could continuously move through all of the stems. 
Additionally, a pump would be used to create flow which could flow in either direction. This 
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design would not require a collection bin as the perfusate would be contained within the stem 
pieces or tubing. 
 
FIGURE 23. PUMP MEDIATED PERFUSION SYSTEM OF STEMS PLACED IN SERIES 
 The advantages of this design are that the stems would allow for recirculating vasculature 
without the liquid being evacuated out by the leaves. Another advantage is that the stems would 
provide a clear path of recirculating media which could easily be controlled by pump driven 
perfusion. Lastly, this is a simple design that would be small and easy to build.  
 The disadvantages of this design are that the stems may be difficult to decellularize, as 
they are more robust than the leaves they are attached to. Additionally, using stems does not 
utilize the natural vasculature of plants which mimics in vivo conditions and thus does not satisfy 
the client’s motivations for the final design. Another disadvantage of this design is that it is 
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limited to the stem only, which only utilizes a small portion of the plant anatomy available to us. 
The final disadvantage of this design is that it does not allow for variable flow between the 
different stem pieces.  
Gravity and pump mediated perfusion system of horizontally oriented leaves 
placed in series 
The next alternative design was a gravity and pump mediated perfusion system of 
horizontally oriented leaves placed in series as seen in Figure 24. This design incorporates 
gravity mediated perfusion in which the leaf lays horizontally on an acrylic board. This acrylic 
board has perforated holes to allow fluid flow from the bottom of the leaf to the lower collection 
chamber. The bottom collection is connected to a tube which facilitates fluid flow from the 
collection chamber to the next leaf in the series. The system will maintain sterility as the leaves 
will be covered with a clear acrylic top for each collection chamber. The tube is connected to a 
needle which is inserted to the stem of the next leaf. This fluid then passes through the 
vasculature of the leaf to allow for full perfusion of the leaf, until the fluid is sweated out by the 
leaf and the liquid falls in to the lower collection chamber. This system continues for the desired 
numbers of leaves. The individual units are placed on top of each other so that gravity can 
mediate the movement of fluid from one leaf to the next. The collection chamber of the bottom 
most unit is connected to tubing which will connect back to the top most leaf. This specific 
movement of fluid will be assisted with the use of a peristaltic pump as the fluid will be moving 
against the direction of gravity.  
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FIGURE 24. GRAVITY MEDIATED PERFUSION SYSTEM OF HORIZONTALLY ORIENTED 
LEAVES PLACED IN SERIES 
 One positive attribute of this design is that the design is compact. This will allow the 
team to easily handle the system when transferring it from the incubator to the sterile hood. 
Another positive attribute of the design is that the design can be one or many chambers. This is 
useful for testing purposes as initially fewer leaves can be used to validate the design and 
additional leaves can be added later for experimental purposes. This design is mostly gravity 
driven versus the use of a peristaltic pump for each leaf which minimizes the cost of design. 
Another positive attribute of this design is that it satisfies all of our defined design objectives.  
 The first negative attribute is that it is very possible for universal failure to occur with this 
design. This means that if one part of the system were to be non-functioning, i.e. one section of 
tubing was clogged, then the entire system would fail. Another negative attribute to this design is 
that it is difficult to control the flow between each leaf. Although a gravity driven system is a 
positive attribute, it can also be seen as a negative attribute as it does not allow for fluid flow 
variability or control by the user. 
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Gravity and pump mediated perfusion system of vertically oriented leaves 
placed in series 
The final alternative design is a gravity and pump mediated perfusion system of vertically 
oriented leaves places in series as seen in Figure 25. This design incorporates the leaves where 
the perfusate is passed from one leaf to another in series. Each leaf would be encased in its own 
sterile unit which would help to avoid contamination. Initially, it was thought that the leaves 
could be connected in series with one set of tubing. It was concluded that if the first leaf in the 
series failed, it could potentially stop the flow of media to the rest of the leaves. If media did not 
flow through all of the leaves, the cells on the leaves could possibly die. Taking possible test 
failures and blockages into consideration, our team designed a new system that would allow for 
flow in the event of test failures and blockages.  
 
 
FIGURE 25. GRAVITY AND PUMP MEDIATED PERFUSION SYSTEM OF VERTICALLY 
ORIENTED LEAVES PLACED IN SERIES  
 To allow flow to different test subjects, a tubing system was designed. The media would 
be stored in a single collection bin that would feed into a pump. There would be a main tube that 
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would allow flow into the first leaf, and from the first leaf, the media would flow to the next leaf 
and so on. The pump tubing, however, would have splits in it leading to each of the other leaves 
to allow for continuous flow to all of the leaves. This would allow for failure in the first leaf to 
be bypassed and continue flow to the other leaves so universal failure would not occur.  
 The advantages of this design are that it satisfies most of the design objectives such as, 
facilitates plant decellularization, has multiple cell types on multiple leaves and models active 
vasculature using plant anatomy. Another advantage to this design is that it has fail safe tubing, 
as described earlier which also allows for the possibility to control flow between each of the 
leaves. Finally, this design is conceptually simply meaning that the design and fluid flow is 
easily understood and not overly complicated.  
One disadvantage of this design is that the plant size is limited by the size of the bottles, 
which would be used to contain the leaves. The leaves would also be oriented vertically. In this 
position the structural integrity of the stem is risked. Along with this, another disadvantage is 
that each individual leaf would need its own bottle, which would require a lot of unnecessary 
materials. Additionally it would be impossible to seed cells onto the leaves without removing 
them from their bottles. This could be a potentially risky and difficult process. The last 
disadvantage of this design is that is large and would take up a lot of space in the incubator or 
sterile hood. It would be difficult to transport and move between the incubator and sterile hood, 
which is essential for any type of cell and tissue culture.  
4.4 Final Design Selection  
To determine the final design, a Pairwise Comparison Chart was created, as seen in Table 
4, to compare each of the alternative design’s and our final chosen design’s abilities to satisfy 
our objectives. Each design was scored based on how well it would meet each objective. From 
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our analysis, we deemed the pump mediated perfusion system of leaves placed horizontally in 
parallel to be the best suited design. 
TABLE 4: PAIRWISE COMPARISON CHART 
 
This chosen design is a modular device, made of acrylic, which can fit in an incubator 
and can be sterilized using ethylene oxide. There are two main components to this design, a 
chamber where the leaves are kept and an electronics chamber to regulate continuous flow. A 
schematic of the design can be seen in Figure 26. 
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FIGURE 26. SCHEMATIC OF CHOSEN DESIGN 
The leaves are place on an acrylic sheet that has small holes to allow the perfusate to fall 
through into a collective reservoir. A peristaltic pump is used to transport the perfusate in this 
reservoir back into the leaves through tubing and a manifold which divides perfusate flow. The 
pump also cycles a small amount of perfusate to a pressure transducer that is controlled by an 
Arduino board which regulates the pressure. There are also two fans, one incoming and one 
outgoing, to regulate heat within the electronics chamber. One fan pulls room temperature air 
from outside of the incubator, through tubing, into the electronics chamber. The other fan pushes 
the warm air from inside of the electronics chamber, through tubing, to the outside of the 
incubator. Since these electronics with be in an incubator, they are coated with an electronic 
grade coating spray which creates a hydrophobic surface, allowing the electronics to function in 
the humidity.    
In prior literature, decellularization has been achieved by elevating the reservoir of 
perfusate above the tissue sample of interest, in order to create gravity driven perfusion. This 
creates a relatively constant pressure that pushes the perfusate through the vascular network of 
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the tissue. Though this setup is sufficient for decellularization purposes it is not ideal for a 
system that must support the growth of cells, due to the fact that it must fit into an incubator. In 
order to fit into an incubator the system must take on a more compact design.   
The pump mediated perfusion system of leaves placed horizontally in parallel system was 
the only design to incorporate all of the design objectives. Since the tubing goes to each leaf 
simultaneously and it has a collective reservoir, it can be used for decellularization as well as cell 
seeding. By making this a two-in-one system, the leaves are not harmed in transport from a 
decellularization device to a system for cell seeding. This is important in maintaining the 
structural integrity of the leaves as decellularized leaves are very fragile and at risk of being 
compromised if they are moved frequently. This system is best able to maintain the structural 
integrity of the leaves because of the tray which provides a flat surface for the leaves to rest on. 
In order to mimic physiological function, multiple leaves can be utilized to house 
multiple cell types within our system. The recirculating perfusate in our system will allow for 
cell type to cell type interactions. In order to maintain cell viability, it is important that the 
system is able to be sterilized and maintain a sterile environment. The system was sterilized 
using ethylene oxide. System sterility was tested by placing media in the reservoir and 
incubating it for two days, with media in all of the tubing. After two days, the media was 
examined under the microscope. No growth was found and the system was declared sterile.  
Having met all the design objectives, the pump mediated perfusion system of leaves placed 
horizontally in parallel was chosen as our final design.   
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V. Design Verification 
            There are many aspects of the final design that had to be tested in order to ensure that the 
best methodologies were being employed to meet our design objectives, constraints and 
functions. This section presents in detail the tests that were performed and the results of each of 
these tests. This chapter will help to further understand the final design choices that were made 
and the supporting verification of those decisions.  
5.1 Functionality in the incubator  
It is imperative that the system is able to operate inside of an incubator to maintain the 
viability of the cells. The environment that the incubator provides is a hostile environment for the 
electronics that regulate the flow of the perfusate. As the inside of the incubator is 37 degrees 
Celsius and has a humidity above 80%, electrical components may experience corrosion and 
shorting of the circuit may occur. Measures were taken to protect the circuit and its components 
from the harsh environment inside the incubator. These measures include a hydrophobic coating 
for the electrical components and fans with intake and outtake tubing from the sealed electronics 
chamber.  
The primary means of protection for the electronic components is a hydrophobic 
electronic grade coating that covers each electronic component. This coating acts as a physical 
barrier between the electronics and the humidity in the air. 
As a secondary means of protection, two small fans were installed in the electronics 
chamber with large diameter tubing leading outside the incubator. These fans exchange the 
humid air from inside the electronics chamber for dryer air outside of the incubator. These fans 
also prevent the electrical components from overheating by providing cool dry air to the chamber.   
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5.2 Successfully decellularizing plants 
          One of the objectives that was originally established for this system is that it should 
facilitate the decellularization of multiple leaves. As previously stated the standard method of 
decellularization involves inserting a cannula into the petiole of the leaf and suspending it 
vertically. An elevated reservoir is then connected to that cannula and passively circulates the 
perfusate through the leaf’s vasculature using gravity. The appearance of the leaf changes 
throughout the decellularization process. The leaf changes from its normal opaque green 
appearance to a translucent green. From there, the leaf loses its color and assumes a clear 
translucent appearance.  
Our system aims to replicate the decellularization quality of the standard method by 
actively circulating the perfusate through the vasculature of the leaf using a peristaltic pump. The 
peristaltic pump is controlled by an Arduino microcontroller which adjusts the speed of the pump 
in order to maintain a constant pressure. A notable difference between the two methods is that 
the leaf assumes a horizontal orientation rather than a vertical one. However, the sequence of 
detergents used for decellularization remains the same. 
            To test the system’s ability to decellularize, leaves were connected to three of the four 
available ports. The last port was sealed for sterilization purposes. All of the leaves rest in a 
horizontal position on the tray.  The protocol used for decellularization can be found in Appendix 
A: Protocol for Plant Decellularization. The first detergent was loaded into the reservoir and the 
Arduino was activated. This Arduino has been programmed using the coding found in Appendix 
F: Software Code for Pump. Once activated the Arduino started the pump with an initial velocity 
of 150 revolutions per minute (rpm). Once the perfusate advanced to the pressure transducer, the 
Arduino began to adjust the speed of the pump to control the range of pressure variation. The 
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perfusate was then free to advance to the manifold where it was divided among the ports. As 
each leaf was perfused, the perfusate was evacuated through the stomata of the leaf and passively 
returned to the reservoir through the holes in the tray. 
             After each step of the decellularization process, the reservoir was emptied and refilled 
with the next solution. The progress of the decellularization was visually assessed throughout the 
process.  The physical appearance of some of the leaves in our system can be seen in Figure 27. 
To prevent contamination of its contents, the user avoided waiving their hands over the open 
chamber and making direct contact with the interior surfaces of the chamber.    
 
FIGURE 27. DECELLULARIZATION PROCESS USING OUR SYSTEM 
 Once the leaves appeared to be completely decellularized, it was histologically confirmed. 
The leaves were processed, embedded in paraffin wax, and cut to a thickness of 8 µm using a 
microtome. A Safranin O and Fast Green stain was used to compare our decellularized leaves 
with those decellularized using the current system. The protocol for this stain can be found in 
Appendix C: Protocol for histological stain for cell wall and cytoplasm. These histology results 
can be seen in Figure 28. 
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FIGURE 28. SAFRANIN O AND FAST GREEN STAIN OF THREE PIECES OF SPINACH AT 20X 
MAGNIFICATION A) SPINACH CONTROL B) DECELLULARIZED SPINACH USING CURRENT 
GOLD STANDARD C) DECELLULARIZED SPINACH USING OUR SYSTEM (BLUE=CELL 
MATERIAL, PURPLE=CELL WALL)  
As seen in Figure 28A the spinach control has blue coloration which indicates that 
cellular material is present. Figure 28B and Figure 28C are decellularized spinach. The absence 
of blue coloration in these images confirms that there is no cellular material present. Figure 28B 
is decellularized spinach using the current gold standard. Figure 28C is decellularized spinach 
using our system.  The absence of blue coloration confirms that our system successfully 
decellularized the spinach leaf. 
5.3 Seeding Cells onto Leaves and Perfusion Testing 
            A main function of our design is to seed cells onto the leaves and allow them to grow. It 
was necessary to confirm that cells could remain in place on the leaf. To test this, a protocol was 
used that is frequently implemented in the Gaudette Laboratory and can be seen in Appendix B: 
Plant Co-culture Protocol.  
            To test the system’s ability to facilitate cell seeding, a sterile decellularized leaf was 
seeded in our system with quantum dot loaded human mesenchymal stem cells (hMSCs). 
Quantum dots are nanoparticles that excite under a narrow UV range. The cell seeding process 
can be found in Appendix B: Plant Co-culture Protocol. After the cells were successfully placed 
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on the leaf they were allowed to grow for 24 hours while being perfused with media. The cells 
were imaged using fluorescent microscopy. The resulting images are found in Figure 29. 
 FIGURE 29. A) CELL SEEDED LEAF IN THE STERILE HOOD B) FLUORESCENT MICROGRAPH 
IMAGE WITH ACTIVATED QUANTUM DOTS OF CELLS SEEDED ON A LEAF C) FLUORESCENT 
MICROGRAPH IMAGE WITH ACTIVATED QUANTUM DOTS OF CELLS SEEDED ONTO A FLASK  
 Figure 29A is an image of a leaf seeded with cells in our system. Figure 29B is a 
fluorescent micrograph image of a leaf seeded with cells. Figure 29C is a fluorescent micrograph 
image of a flask seeded with cells.  Due to the presence of quantum dots in Figure 29B, it can be 
confirmed that the cells were successfully seeded onto the leaf.  
5.4 Cell Viability 
          In addition to testing the ability to seed cells onto the leaves, it was also necessary to 
determine that the cells could survive media perfusion. This is essential because the final design 
will perfuse media through the petiole in order to create a recirculating system while also 
maintaining cell viability. Cells were seeded onto a leaf as described in Appendix B: Plant Co-
culture Protocol. The leaf is stained with ethidium homodimer-1 which places a red label on the 
nucleus of dead cells. Phalloidin and Hoechst were used as counter stains to label the 
cytoskeleton and nuclei respectively. As a result all cells will appear to have green bodies with 
nuclei present. Live cells will appear to have blue nuclei, whereas dead cells will appear to have 
purple nuclei. The purple color is due to the overlay of the blue and red from the Hoechst dye 
A 
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and the ethidium homodimer-1. This protocol can be found in Appendix D: Protocol for 
live/dead stain. The resulting image can be seen in Figure 30. 
 
FIGURE 30. ETHIDIUM HOMODIMER-1 (RED), PHALLOIDIN (GREEN), AND HOECHST (BLUE) 
STAIN OF SEEDED LEAF 
 There are blue cells present in Figure 30 with no red color overlaying them. This 
indicates that cells were viable on the leaf after 24 hours. 
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VI. Final Design and Validation 
6.1 Final Design Description 
The final design of the pump mediated decellularization and cell seeding system consists 
of two acrylic chambers. These chambers were drafted in Solidworks and assembled using 
acrylic sheets and acrylic cement. The first chamber hosts a reservoir for fluid agents and a 
horizontal support tray on which the cannulated leaves rest as seen in Figure 31. This chamber’s 
top side is attached to a hinge allowing easy access to the fluids, leaves and cannulas for 
preparing the system. This will also allow the user to seed cells onto the plants. The second 
chamber houses an Adafruit peristaltic pump, power source, pressure transducer, two fans and an 
Arduino microcontroller as seen in Figure 32. The first fan draws cool, dry air from outside of 
the incubator into the electronics chamber using tubing and a second fan expels the warm air 
from the chamber outside the incubator using tubing. Silicone tubing is used to connect both 
chambers and a manifold is used to divert fluid flow. 
 
FIGURE 31. CHAMBER 1 WHICH HOSTS A RESERVOIR FOR FLUID AGENTS AND A 
HORIZONTAL SUPPORT TRAY ON WHICH THE CANNULATED LEAVES REST 
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FIGURE 32. CHAMBER 2 WHICH HOSTS AN ADAFRUIT PERISTALTIC PUMP, POWER SOURCE, 
PRESSURE TRANSDUCER, 2 FANS AND AN ARDUINO MICROCONTROLLER   
 Chamber one is completely detachable from the system and has been designed to be 
sterilized via ethylene oxide. Detachable silicone tubing is fixed to the bottom of chamber one’s 
reservoir through which the fluid agents are pumped. The fluids enter chamber two and reach a 
transducer which collects pressure data. This data is translated by the Arduino microcontroller 
which has been programmed to control the rate of the pump based on this pressure data. The 
fluids exit chamber two and reaches a manifold where flow is divided into five separate ports. 
The fluid in each port then reenters chamber one and is pumped through the cannulated lumen of 
a leaf where it is perfused throughout the microvasculature. The fluid then exits the leaf through 
the stomata and returns to the reservoir for recirculation. The system’s fluids are changed 
throughout the process in accordance with the decellularization and cell seeding protocols found 
in Appendix A: Protocol for Plant Decellularization and Appendix B: Plant Co-culture Protocol 
respectively. The process in which the design functions is visualized in Figure 26. 
6.2 Achieving the objectives 
 Our client was seeking a systems biology device which involves the decellularization and 
cell seeding of leaves within the same perfusion system to form a biomimetic body that mimics 
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physiological systems in vivo. To do this, we identified, addressed, and tested five crucial 
objectives for our design. 
1. Protect the structural integrity of the plant 
The design must protect the structural integrity of the leaf in order to ensure that perfusion 
occurs properly, for in the event that the structural integrity is compromised incomplete 
decellularization or cell death may occur. To achieve this objective cannulation methods were 
analyzed using a red dye perfusion test for their ability to protect the leaf’s vasculature as 
described in Feasibility Study 1: Determining the best method of cannulation. After choosing the 
most effective method, which was the clip method, a horizontal tray was also incorporated on 
which the leaf may rest to prevent motion of the leaf. 
The ability to protect the structural integrity of the leaf was proven following successful 
decellularization attempts using the device. In the event that the leaves’ structural integrity 
became compromised, full decellularization would not have been possible. 
2. Able to facilitate plant decellularization and cell seeding  
 The design must facilitate the decellularization and cell seeding of plants. In order to 
model the human body, plant cells must be removed and human cells must be seeded onto the 
leaf. To achieve this objective our device was outfitted with the capabilities of executing the 
decellularization and cell seeding protocols found in Appendix A: Protocol for Plant 
Decellularization and Appendix B: Plant Co-culture Protocol respectively through the use of our 
fluid reservoir and pump mediated perfusion system.  
 We assessed the efficacy of decellularization by using a histological stain that stains for 
cell wall and cytoplasm. This was done by processing the leaf, embedding it in paraffin wax, 
cutting the leaf via microtome and using Safranin O and Fast Green stain (protocol can be found 
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in Appendix C: Protocol for histological stain for cell wall and cytoplasm. Images were analyzed 
qualitatively and observed to show that the samples were adequately decellularized.  
We assessed the efficacy of cell seeding by loading cells onto the leaves with quantum dots. 
Images were analyzed qualitatively and observed to show that cells were successfully seeded 
onto the decellularized plants. 
3. Ability to host multiple cell types on different leaves. 
The system must incorporate different cell types that are physically isolated from one 
another. Different cell types are needed to model the complex human body and the interactions 
that occur between cells in vivo. The cellular communication can then be used as in “in vitro 
model for drug screening” as stated in the client statement. This objective was addressed using a 
manifold which allowed us to create up to four organoids living on the same interconnected 
system. Cells from one leaf may produce a metabolite that will be released into the reservoir, 
where it is mixed in with the complete media and pumped to the other organoids. 
 We assessed our ability to host multiple cell types on different leaves by seeding cells 
onto a leaf and using a live/dead assay.  Phalloidin, Hoechst, and ethidium homodimer-1 were 
used in conjunction with one another to obtain a fluorescent image confirming that cells were 
alive at the after 24 hours on a leaf as seen in Figure 30. By determining that cell viability was 
maintained on one leaf, we can infer that multiple cell types can survive on multiple leaves in our 
system. 
4. Model active microvasculature using plant anatomy 
 The design must model active vasculature using plant anatomy as the current gold 
standard of drug screening currently lack this ability. The main premise of our design involves 
the use of decellularized leaves’ microvasculature as a means of delivering nutrients and drugs to 
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cells seeded onto them. By successfully building a system that maintains the viability of cells 
seeded onto a plant via perfused media we have modeled the active microvasculature using plant 
matter.   
5. Provide stable extracellular substrate 
The design must allow for a stable extracellular substrate. Once decellularized, the plant 
matter becomes very fragile and is at a great risk for damage. The design must ensure that the 
leaf is stable and protected. Any damage to the leaf may cause harm to the cells seeded onto the 
leaf. 
The ability to protect the structural integrity of the leaf was proven following successful 
decellularization attempts using the device. If the leaves’ structural integrity became 
compromised, full decellularization would not have been possible. 
6.3 Design Standards 
It is important that our device, testing procedures, and maintenance procedures satisfy 
each ISO requirement. Section 3.7 of ISO 13485:2003 characterizes our plant based profusion 
system as a medical device in that it “provides information for medical purposes by means of an 
in vitro examination of specimens derived from the human body”. Because this device is a novel 
means for screening drugs, there have not been any ISO standards written for this specific device. 
Following further production, our decellularization and cell seeding device will need to be 
addressed by ISO and the FDA regarding proper use and whether or not it can be used as a 
suitable substitute for the conventional methods of drug screening.  
6.4 Economics  
Our client was seeking a new device for preclinical drug screening. Every year 
pharmaceutical companies spend billions of dollars completing preclinical and clinical studies in 
order to achieve FDA approval and enter the market. It is financially devastating when a 
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company wastes hundreds of millions of dollars on a compound only for it to fail in the late 
stages of clinical trials. We believe that the technology we researched, developed, and trialed can 
prevent compounds likely to fail from entering very expensive clinical trials by providing the 
researchers with a more accurate preclinical testing model. Consequently, the economic impact 
of this device is significant as it can overcome the limitations of the current gold standard for in 
vitro preclinical drug screening and become a marketable solution for pharmaceutical companies.  
6.5 Environmental impact  
Our device which was researched, developed and manufactured is expected to have very 
little environmental impact. All material components including acrylic walls, silicone based 
tubing, Arduino microcontroller, manifold, fans, copper wiring, cannulas, clips, batteries and 
spinach leaves are all common materials that are either permanent fixtures, recyclable, or very 
safely disposable. The potentially harmful chemicals required for decellularization and cell 
seeding including hexanes, 10% SDS, 0.1% Triton-X 100, 10% bleach, PBS and cell culture 
media are to be used only within a laboratory setting that is equipped with the proper means of 
disposal.  
6.6 Societal Influences 
 It is not expected that our device will be recognized by the average citizen. However, 
there are major societal implications within the pharmaceutical, educational, and scientific 
communities. This technology features decellularized plants, a novel concept to the field of 
tissue engineering. This approach could potentially inspire an entire new field of cross-kingdom 
regenerative engineering. A massive field expansion will inspire new novel devices, treatments, 
and mindsets to impact and save countless lives. 
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6.7 Political ramifications 
 The political and legal implications of the technology developed for this project mostly 
lie in government regulation of pharmaceutical testing. The device is designed as an alternative 
to 2D and 3D cell culture methods, high-throughput screening, and the current gold standard, 
organs-on-chips. For these reasons, the FDA will have great interest in this device. As a result, a 
new standard operating procedure (SOP) will need to be established and monitored for our 
device. Globally, ISO will have to verify the quality of the device in order to maintain the current 
global standard for preclinical research. Additionally, one must consider that companies who 
have used our device to prevent monetary loss will generate more revenue. This can be used for 
lobbying political institutions and garnering support from officials.  
6.8 Ethical Concerns 
Our device proposes a new solution to an ethical problem that has plagued the scientific 
community for years. This ethical problem is clinical testing on animal subjects. Many people 
view this as cruel and inhumane. Our system offers a safe alternative to this problem. Instead of 
using animals for testing, human cells are used. This eliminates the need for animals and offers a 
direct view of a compounds effect on human cells.   
A new ethical concern arises with the use of human cells. This new concern is with the 
use of organoids. The question may be posed, when would they be considered alive? They are 
live cells but when they start functioning as a tissue would they be considered alive? Some may 
argue that it is unethical to try and recreate organs which are naturally occurring in humans.   
6.9 Health and Safety 
 Our device is intended to be used as a preclinical method for screening drugs before they 
enter clinical trials. In operation our device will alert researchers of any potential harmful effects 
on different organs. Our device also accounts for microvascular drug absorption and organ to 
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organ interactions. With an accurate model for drug screening, researchers can prevent harmful 
compounds from reaching clinical trials, thus protecting the health and safety of participants in 
these studies.  
6.10 Manufacturability 
The decellularization and cell seeding system was manufactured using the machine shop 
at Higgins Laboratory at Worcester Polytechnic Institute. All components used in our prototype 
were conventional materials that were processed with a laser cutter, drill press and tap. Common 
electrical components were used including a breadboard, peristaltic pump, pressure transducer, 
Arduino Uno, and fans. Acrylic cement and caulking were used to prevent any leakages of fluid 
at the acrylic interfaces. Upon completion of the SolidWorks drawings the manufacturability is 
simple. Because of its simplicity, there is potential, in later device iterations, for mass production. 
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VII. Discussion 
Over the course of this project, many feasibility and validation studies have been 
conducted, results collected, and data analyzed. Each experiment was necessary to prove that the 
design was validated properly and fulfilled the client's needs. These experiments include the 
verification of decellularization, cell seeding and cell viability.  
7.1 Decellularization 
One of the primary function of this system is to facilitate the decellularization process of 
leaves. To test this, three leaves were attached to the system. The leaves used in this experiment 
had their cuticles removed prior to attachment to the system. The protocol for cuticle removal 
can be found in Appendix A: Protocol for Plant Decellularization. After attachment to the system 
the leaves were then exposed to a sequence of solutions as listed in the plant decellularization 
protocol. After the decellularization process, decellularization was visually confirmed by the 
leaves’ clear translucent appearance.  
A leaf was processed, embedded in paraffin wax, and cut into 8µm section using a 
microtome. Decellularization was histologically confirmed with a Safranin O and Fast Green 
stain. The Safranin O and Fast Green stain makes cellular material appear blue, while the cell 
walls appear pink. The results can be seen in Figure 28. Compared to the control image in Figure 
28A and the example from the Gaudette lab in Figure 28B, the leaf from our system was 
successfully decellularized. This can be justified by its lack of blue coloration and intact cell wall 
structures. 
7.2 Cell seeding 
An important step of testing out design is ensuring cells can be seeded on decellularized 
leaves. To test cell attachment to the leaf, cells were first loaded with quantum dots. Quantum 
dots are ideal for this application because of their narrow spectrum of excitation. This narrow 
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spectrum reduces the auto-fluorescence of the surroundings. The quantum dot loaded cells were 
then seeded onto the leaf according to the cell seeding protocol described in Appendix B: Plant 
Co-culture Protocol. Cell seeding was found to be successful by the presence of quantum dots on 
the decellularized leaf. 
7.3 Cell viability 
The fact that the cells have adhered to the surface of the decellularized leaf does not 
insure that the cells are viable. The agents used to decellularize the leaf are toxic to the cells, and 
trace amounts of these agents could cause the cells to die. The viability of the cells is essential to 
conducting any further studies on the cells and a compounds effects. To assess cell viability, 
cells were seeded onto a decellularized leaf. Once seeded the cells were incubated for an 
additional 24 hours. The leaf was then stained according to the protocol in Appendix D: Protocol 
for live/dead stain. The results of this stain can be seen in Figure 30.  
Ethidium homodimer-1 appears red and only stains the nuclei of dead cells. Phalloidin 
appears green and stains the F-actin in the cytoskeleton of all cells. Finally Hoechst stains all 
nuclei blue. As a result of the overlaid images, live cells will appear to have a green cytoskeleton 
with blue nuclei. Dead cells will appear to have green cytoskeletons with purple nuclei. In Figure 
30 there are few cells with purple nuclei and several cells can be spotted with blue nuclei. These 
results prove that not only are the cells capable of adhering to the surface of the leaf, they can 
also remain viable. The results collected throughout these studies prove that decellularized leaves 
can act as a platform for tissue engineering and drug screening applications. 
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VIII. Conclusion and Recommendations 
 The team has designed and created a system for decellularization and cell seeding of 
plants that maintains sterility, cell viability and the structural integrity of the leaves. The design 
is a low-cost product which utilizes active vasculature and maintains cell viability. Using our 
design, the team was able to decellularize leaves using a combination of different detergents. 
Additionally, the team was able to seed cells onto the decellularized leaves and maintain cell 
viability for 24 hours. Overall, this system has met the client’s expectations and has allowed for 
the progression of research involving the combination of plant material and animal cells for 
tissue engineering and drug screening applications. 
 Throughout the completion of this design process, future improvements and areas for 
continued research were highlighted and documented. Cell viability is essential to conducting 
further studies of a compound’s effect. Although cell viability was determined using our system, 
other methods are also available in order to determine cell viability in a more quantitative 
method.  
 One possible way to test cell viability is through the use of alkaline phosphatase. Alkaline 
phosphatase is produced by specific cells, such as bone and liver cells, when they are healthy and 
thriving. When these specific cells are unhealthy, they do not produce the alkaline phosphatase. 
When present, alkaline phosphatase can be stained and imaged using light microscopy. This is 
important as some materials on the leaf produce auto-fluorescence when using fluorescence 
microscopy. The auto-fluorescence makes identifying structures on the leaf difficult. If alkaline 
phosphatase were to be imaged for, using light microscopy, the health of the cells can be 
assessed. Due to budget constraints, alkaline phosphatase cells were not able to be purchased for 
73 | P a g e  
 
research purposes. However, if this project were to be completed in the future with more funding, 
alkaline phosphatase cells could prove to be very useful in determining cell viability on a leaf.  
 The system was created in order to facilitate the growth of different cell types on each 
leaf. In the future, it is hoped that this system is able to facilitate the growth of different 
organoids, originating from different cell types on different leaves. By growing entire organoids 
on the same perfusion system, a biomimetic body could be created for drug screening purposes.  
 The system that was created was designed in such a way to allow for cell type to cell type 
communication between the different leaves. The tubing and reservoir aim to allow the cells to 
communicate through chemical signals passed through the media. If this project were to be 
advanced in the future, a methodology for collecting data on evidence of cell interactions and 
further organoid interactions should be established.  
 Overall, the system was created in order to overcome the current limitations of the 
preclinical drug screening processes such as organs-on-chips. It would be ideal to perform drug 
screening activities with our design to determine if this is possible. Drug screening activities may 
include introducing a drug to the system and then collecting data on the different cell type and 
organoid responses.  
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Appendix A: Protocol for Plant Decellularization 
This is the protocol used for plant decellularization provided by the Gaudette Laboratory.   
Protocol for Plant Decellularization 
Used for spinach (and other) leaves, parsley stems 
Materials: 
• Cannulas (20G) 
• Hexanes 
• PBS 1x 
• DI H2O 
• 10X SDS solution in DI H2O 
• 0.1% Triton-X with 10% bleach (Cl tablets) in DI H2O 
o Ex: If using 4g Cl tablets, place in 4L of solution. 
• Same protocol applies if using Gaudette Lab decellularization apparatus or custom set-up. 
o Gaudette decellularization apparatus requires ~2-4L of each solution to function 
efficiently. Custom decellularization apparatus should use an appropriate amount 
of solution depending on size. 
Protocol: 
1. Wash leaves and/or stems in DI water. 
2. Submerge in hexanes and wash vigorously for 2 minutes. Remove and rinse in 1x PBS 
for 2 minutes (Repeat 3x times).  
3. Cannulate leafs and parsley stems via the stem, affixing cannulas with glue or suture. If 
using glue, use sparingly to ensure flow is not obstructed.  
4. Once leaves are cannulated, allow glue to dry (if used), keeping plant material hydrated 
with DI H2O. 
5. Use syringe to validate flow: perfuse a small amount (~1mL) of DI water through the 
cannula to verify that there is unobstructed flow through the leaf. 
6. Affix plant materials to decellularization set up. 
7. Attach 10x SDS solution to the set up and begin flow. Monitor plant materials to ensure 
proper flow through the leaf vasculature, modifying flow rate to ensure a slow, steady 
drip. 
a. Rapid flow rate will deplete SDS too quickly, whereas too little flow runs the risk 
of dehydrating the plant material and damaging the plant structure. 
8. Maintain in SDS for 5 to 7 days in order to decellularize plant material, until leaves and 
stems become more transparent in appearance. Green coloration at this step is normal and 
not indicative of an unsuccessful decellularization. 
9. Remove 10x SDS and attach Triton-X/Bleach solution to set up.  
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10. Maintain set up in Triton-X/Bleach for 24-48 hours, or until leaves and stems have 
become clear/transparent. This solution should purge any remaining coloration from the 
plant matter. 
11. Remove Triton-X/Bleach solution and attach DI H2O to set up. Perfuse leaves/stems in 
DI H2O for 24 hours. 
12. Remove leaves and stems, store in DI H2O at 4 degrees Celsius until needed. 
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Appendix B: Plant Co-culture Protocol  
Plant Co-culture (For PLANTIMAL MQP):  
1. Decellularize leaf 
2. Sterilization: 
o In 10cm dish containing decelled leaf, add the following: 
 10mL 10% bleach 
 1mL 0.1% Triton-X 
o Agitate gently on shaker table for 30 minutes 
o Transfer leaf to Laminar Flow hood 
o Aspirate sterilization solution 
o Rinse 3x with sterile water 
o Rinse 3x with sterile PBS 
o Section leaf for plating with sterile tweezers and scalpel/razor 
o NOTE: Leaf should change from opaque (after the decell process), to translucent 
(after sterilization) 
3. Incubate the leaf in media overnight to equilibrate leaf to salinity of media 
4. Chelate leaf with sterile 2mM EDTA in PBS 
i. Add EDTA to fresh well 
ii. Introduce leaf to EDTA well and gently rock back and forth by hand for 
45-60 seconds taking care to coat whole leaf section 
iii. GENTLY dry leaf section on edge of Kimwipe to remove excess EDTA 
5. Secure leaf solidly to the bottom of a petri dish 
a. Have been using Gaudette-Pins Transwell but a sterile washer should suffice 
b. Want to make sure surface is taut and solid to stiff bottom of petri dish 
6. Seed cells to surface 
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Appendix C: Protocol for histological stain for cell wall 
and cytoplasm 
Brief protocol for fixation and staining of both normal/ decellularized leaf samples: 
1. Fix on “routine” cycle in tissue processor 
2. Section at 14 um 
3. Deparaffinize, bring to H20 ( per usual method ) 
4. Stain 1 hour, aqueous Safranin O ( 1% w/v ) 
5. Wash in DI until sections clear of residual dye ( 5 mins, approx ) 
6. Dehydrate up to 95% EtOH ( 2-5 mins/ step) 
7. Dip 10s in 95% EtOH + Fast Green FCF ( 0.1% w/v ) 
8. Wash (2x – 2 min each step) in 100% EtOH 
9. Clear in at least 2 changes of xylene, mount, image 
 
Expanded protocol for Safranin O/Fast Green (Sass’s Method) 
1. Make up safranin O (1% w/v in DI water) 
2. Make Fast Green (0.1% w/v in 95% EtOH) 
3. Deparaffinize and hydrate in two changes of xylene; two changes 100% EtOH; 1 change 
95% EtOH, 1 change 70% EtOH; 1 change DI H20 (2 mins, each step). 
4. Stain for 1 hour in aqueous Safranin O. 
5. Rinse in tap water until sections cleared of residual dye (~ 5 mins) 
6. Dehydrate to 95% EtOH (2 mins). 
7. Dip for 10 seconds in Fast Green stain. 
8. Immediately wash in 100% EtOH (2x, 2 mins). 
9. Clear in xylenes, mount with coverslip.  
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Appendix D: Protocol for live/dead stain 
Solutions: 
Solution 1: 
• 1.0 mL Serum Free DMEM 
• 2.0 µL Ethidium Homodimer-1 
Solution 2: 
• 1.0 mL Serum Free DMEM 
• 2.0 µL Ethidium Homodimer-1 
Phalloidin (AF 488 Phalloidin A12379, Invitrogen): 
• 2.5% V/V Phalloidin in PBS 
• 50 µL in 1950 µL PBS 
Hoechst: 
• 0.0167% Hoechst dye in PBS 
• 0.5 µL in 3000 µL PBS 
Process: 
1. Turn off the lights 
2. Mix solution 1 within 1 hour of use 
3. Let cells sit with solution 1 for 15 minutes, then aspirate 
4. Mix solution 2 within 1 hour of use 
5. Let cells sit with solution 2 for 15 minutes, then aspirate 
6. Wash cells with 1x PBS, 6 times 
7. Fix cells with 4% phosphate buffered formaldehyde for 10 minutes 
8. Rinse with PBS, 2 times 
9. Add Triton-X solution, let sit 10 minutes, then aspirate 
10. Rinse with PBS, 2 times 
11. Block with BSA solution for 30 minutes 
12. Add Phalloidin solution, let sit for 30 minutes, then aspirate 
13. Rinse with PBS, 2 times 
14. Add Hoechst solution, let sit for 3 minutes, then aspirate 
15. Rinse with PBS, 2 times 
16.  Store at –20 degrees C 
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Appendix E: Gantt Chart 
 The Gantt Chart for this project was created using Microsoft Project Software. The 
resulting Gantt Chart can be seen below. 
 
 Zoomed in sections of the Gantt Chart are provided below for clarity.  
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Appendix F: Software Code for Pump 
This code was generated using the sample code from adafruit.com 
For use with the Adafruit Motor Shield v2  
#include <Wire.h> 
#include <Adafruit_MotorShield.h> 
#include "utility/Adafruit_MS_PWMServoDriver.h" 
 
// Create the motor shield object with the default I2C address 
Adafruit_MotorShield AFMS = Adafruit_MotorShield();  
// Or, create it with a different I2C address (say for stacking) 
// Adafruit_MotorShield AFMS = Adafruit_MotorShield(0x61);  
 
// Select which 'port' M1, M2, M3 or M4. In this case, M1 
Adafruit_DCMotor *myMotor = AFMS.getMotor(1); 
// You can also make another motor on port M2 
//Adafruit_DCMotor *myOtherMotor = AFMS.getMotor(2); 
void setup() { 
   
  AFMS.begin();  // create with the default frequency 1.6KHz 
  //AFMS.begin(1000);  // OR with a different frequency, say 1KHz 
   
  // Set the speed to start, from 0 (off) to 255 (max speed) 
  
  myMotor->setSpeed(150); 
  myMotor->run(FORWARD); 
  // turn on motor 
  myMotor->run(RELEASE); 
   Serial.begin(9600); 
} 
int i=150; 
void loop() { 
  // put your main code here, to run repeatedly: 
 int Vs=5.1; 
int sensorValue= analogRead(A0); 
float Vout = sensorValue * (5.0 / 1023.0); 
float p=(0.04/0.004)+(Vout/(Vs*0.004)); 
float Pf=p/0.13332239; 
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    if (Pf<=800) { 
       i=i+5; 
       myMotor->setSpeed(i); 
  myMotor->run(FORWARD); 
   
  Serial.print(Pf); 
  Serial.print(" "); 
  Serial.println(i); 
  delay (500); 
    } 
    else   
        
      { i=i-5; 
        myMotor->setSpeed(i); 
  myMotor->run(FORWARD); 
   
   Serial.print(Pf); 
  Serial.print(" "); 
  Serial.println(i);  
   delay(500); 
  } 
  if (i<=180) 
  {i=180;} 
  if (i>=255) 
  {i=200;} 
}       
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Appendix G: Circuit Diagram 
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Appendix H: Final Design and Solidworks Drawings 
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